Tocilizumab-induced mucosal injury in the terminal ileum mimicking intestinal Behçet’s disease: A case report

Tocilizumab, a humanized anti-interleukin-6 (IL-6) receptor monoclonal antibody, is used for the treatment of adult-onset Still disease (AOSD). Despite its efficacy in many clinical situations, concerns have been raised regarding intestinal mucosal injury in patients receiving tocilizumab. PATIENT C...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozaka, Sotaro, Fukuda, Masahide, Takahashi, Haruhiko, Tsutsumi, Koshiro, Iwao, Masao, Hirashita, Yuka, Fukuda, Kensuke, Okamoto, Kazuhisa, Arakawa, Mie, Ogawa, Ryo, Endo, Mizuki, Mizukami, Kazuhiro, Kamiyama, Naganori, Kobayashi, Takashi, Kodama, Masaaki, Murakami, Kazunari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289693/
https://www.ncbi.nlm.nih.gov/pubmed/37352037
http://dx.doi.org/10.1097/MD.0000000000034118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289693/
https://www.ncbi.nlm.nih.gov/pubmed/37352037
http://dx.doi.org/10.1097/MD.0000000000034118

Ejemplares similares